Imperial College London
Portrait Picture

Dr. Jia Li

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Reader in Biological Chemistry
 
 
 
//

Contact

 

+44 (0)20 7594 3230jia.li

 
 
//

Location

 

10.N2ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ferreira:2019:10.1158/1078-0432.CCR-19-0960,
author = {Ferreira, MR and Andreyev, HJN and Mohammed, K and Truelove, L and Gowan, SM and Li, J and Gulliford, SL and Marchesi, JR and Dearnaley, DP},
doi = {10.1158/1078-0432.CCR-19-0960},
journal = {Clinical Cancer Research},
pages = {6487--6500},
title = {Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late-radiation enteropathy},
url = {http://dx.doi.org/10.1158/1078-0432.CCR-19-0960},
volume = {25},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Purpose: Radiotherapy is important in managing pelvic cancers. However, radiation enteropathy may occur and can be dose limiting. The gut microbiota may contribute to the pathogenesis of radiation enteropathy. We hypothesized that the microbiome differs between patients with and without radiation enteropathy.Experimental Design: Three cohorts of patients (n = 134) were recruited. The early cohort (n = 32) was followed sequentially up to 12 months post-radiotherapy to assess early radiation enteropathy. Linear mixed models were used to assess microbiota dynamics. The late cohort (n = 87) was assessed cross-sectionally to assess late radiation enteropathy. The colonoscopy cohort compared the intestinal mucosa microenvironment in patients with radiation enteropathy (cases, n = 9) with healthy controls (controls, n = 6). Fecal samples were obtained from all cohorts. In the colonoscopy cohort, intestinal mucosa samples were taken. Metataxonomics (16S rRNA gene) and imputed metataxonomics (Piphillin) were used to characterize the microbiome. Clinician- and patient-reported outcomes were used for clinical characterization.Results: In the acute cohort, we observed a trend for higher preradiotherapy diversity in patients with no self-reported symptoms (P = 0.09). Dynamically, diversity decreased less over time in patients with rising radiation enteropathy (P = 0.05). A consistent association between low bacterial diversity and late radiation enteropathy was also observed, albeit nonsignificantly. Higher counts of Clostridium IV, Roseburia, and Phascolarctobacterium significantly associated with radiation enteropathy. Homeostatic intestinal mucosa cytokines related to microbiota regulation and intestinal wall maintenance were significantly reduced in radiation enteropathy [IL7 (P = 0.05), IL12/IL23p40 (P = 0.03), IL15 (P = 0.05), and IL16 (P = 0.009)]. IL15 inversely correlated with counts of Roseburia and Propionibacterium.Conclusions: The microbiota presents opportunities t
AU  - Ferreira,MR
AU  - Andreyev,HJN
AU  - Mohammed,K
AU  - Truelove,L
AU  - Gowan,SM
AU  - Li,J
AU  - Gulliford,SL
AU  - Marchesi,JR
AU  - Dearnaley,DP
DO  - 10.1158/1078-0432.CCR-19-0960
EP  - 6500
PY  - 2019///
SN  - 1078-0432
SP  - 6487
TI  - Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late-radiation enteropathy
T2  - Clinical Cancer Research
UR  - http://dx.doi.org/10.1158/1078-0432.CCR-19-0960
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494399300022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://clincancerres.aacrjournals.org/content/25/21/6487
VL  - 25
ER  -
Download